IP Library Granted Patent US 10,226,516
Granted Patent B2
US 10,226,516 · App. 15/373,506 · Granted Mar 12, 2019

Process, tube and device for the preparation of wound healant composition

Inventor: Antoine Turzi (Mollens, CH)
Assignee: RegenLab USA LLC
A61K38/4833A61K8/981A61K8/983A61K31/728A61K35/14A61K35/15A61K35/16A61K35/17A61K35/18A61K35/19A61K38/363A61L26/0057A61L26/0066A61M1/0209A61M1/029A61M5/19A61Q19/08C12Y304/21005A61L2300/30A61L2300/412A61M2202/0425A61M2202/0427
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,226,516
App. No.
15/373,506
Granted
Mar 12, 2019
Kind
B2
Abstract

The present invention is related to the field of tissue regeneration. It concerns more particularly new processes, tubes and devices for thrombin, platelet concentrate and wound healant preparations, alone or in combination with cell extracts, cell compositions and uses thereof.

Claims (37)

1. A separator system for the preparation of a thrombin serum from whole blood, comprising:

a tube;

a thixotropic gel disposed in the tube and whole blood introduced into the tube, the thixotropic gel adapted for separating thrombin serum from whole blood introduced into the tube;

the tube adapted to be centrifuged for a sufficient length of time until separation of the thrombin serum from the whole blood by the thixotropic gel;

the thixotropic gel adapted for separating the thrombin serum such that the thrombin serum contains less than 1% red blood cells compared to the whole blood;

the tube containing no other additive other than the thixotropic gel prior to introduction of the whole blood, the tube sterilized and hermetically sealed with the thixotropic gel therein;

an applicator adapted to administer a mixture of the thrombin serum and a platelet concentrate to a patient.

2. The system of claim 1 , wherein centrifugation is performed at a force between about 1000 g and about 2000 g for a time selected from about 20 minutes up to about 40 minutes, or at a force of about 1500 g for a time selected from about 25 minutes up to about 35 minutes, or at a force of about 1500 g for about 30 minutes.

3. The system of claim 1 , wherein said tube is a glass tube.

4. A method for the preparation of a thrombin serum comprising:

centrifuging whole blood in the separator system according to claim 1 until separation of the thrombin serum.

5. The system according to claim 1 , wherein said platelet concentrate is admixed to said thrombin serum in ratio of about 1:1, about 3:1, or about 10:1.

6. The system according to claim 1 , wherein said thrombin serum and said platelet concentrate are prepared simultaneously.

7. The system according to claim 1 , wherein said thrombin serum and said platelet concentrate are prepared by centrifugation for about 8 minutes to about 10 minutes.

8. The system of claim 1 , wherein the thrombin serum is autologous.

9. The system of claim 1 , further comprising the whole blood and the thrombin serum.

10. A separator system for the preparation of a thrombin serum from whole blood, comprising:

a tube suitable for centrifugation;

a thixotropic gel disposed in the tube and whole blood introduced into the tube, the thixotropic gel adapted for separating thrombin serum from whole blood introduced into the tube, such that the thrombin serum contains less than 1% red blood cells compared to the whole blood; and

a coagulation activator disposed in the tube,

the tube sterilized and hermetically sealed with the thixotropic gel and the coagulation activator therein;

wherein the tube only contains the thixotropic gel, disposed below the coagulation activator, prior to introduction of the whole blood.

11. A method for the preparation of a thrombin serum comprising:

centrifuging whole blood in the separator system according to claim 10 until separation of the thrombin serum.

12. A kit comprising:

a separator system according to claim 1 ; and

phlebotomy accessories.

13. The kit of claim 12 , further comprising:

a double syringe for simultaneous dispensation of the thrombin serum and the platelet concentrate.

14. The kit of claim 12 , further comprising:

a centrifuge for centrifuging the tube.

15. A separator system for the preparation of a thrombin serum from whole blood, comprising:

a glass tube adapted to be centrifuged;

a thixotropic gel disposed in the tube and whole blood introduced into the tube, the thixotropic gel adapted for separating thrombin serum from whole blood when centrifuged for about 8 minutes to about 10 minutes, such that the thrombin serum contains less than 1% red blood cells compared to the whole blood;

the tube sterilized and hermetically sealed with the thixotropic gel therein;

wherein the tube only contains the thixotropic gel, or only the thixotropic gel and a coagulation activator, and no other additives, prior to introduction of the whole blood in the tube.

16. The system of claim 15 wherein the tube comprises the coagulation activator.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 10, 2018
From: TURZI, ANTOINE
To: REGENLAB USA LLC
Reel/Frame 045490/0245 →
Priority Claims (1)
GB 1004072.3 · Mar 11, 2010 · national
Continuity (3)
Division 14596268 · Jan 14, 2015
Division 13634020
Related Publication 20170087228A1 · Mar 30, 2017